Shares of Viatris Inc. VTRS advanced 1.72% to $11.25 Friday, on what proved to be an all-around rough trading session for the ...

Viatris VTRS, a global healthcare company, is scheduled to report fourth-quarter and full-year 2024 results on Feb. 27, 2025.

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Shares of Viatris Inc. VTRS advanced 1.19% to $11.06 Thursday, on what proved to be an all-around dismal trading session for ...

Siddiq, Biotricity Founder & CEO, said, “In the third quarter of fiscal 2025, we continued our mission to innovate a ...

Reports Q4 revenue EUR65.68M from EUR65.30M last year. CEO Brigitte de Vet-Veithen commented, “In the final quarter of 2024 our Materialise ...

OpenAI’s big rebranding effort brings a new logo and a new typeface, OpenAI sans. OpenAI’s big rebranding effort brings a new logo and a new typeface, OpenAI sans. Emma Roth is a news writer ...

Tesla misses analyst estimates for revenue and earnings per share in the fourth quarter. The automaker updated investors on its upcoming vehicle production. Get two weeks of free access to pro ...

and Viatris is profitable, guiding for Adjusted EBITDA of $4.7bn, free cash flow of $2.37bn, and adjusted earnings per share ("EPS") of $2.64, in 2024, which translates to a price to earnings ("P ...

Viatris Inc. (VTRS), headquartered in Canonsburg, Pennsylvania, is a leading global healthcare company dedicated to empowering people worldwide to live healthier at every stage of life. With a ...